On September 24, 2026, TOUYUN BIOTECH (01332) announced that it granted share options under its share option scheme to one director and 22 employees, allowing them to subscribe for a total of 74.5838 million ordinary shares of the company with a par value of HK$0.04 each, subject to acceptance by the grantees.

The grant was made pursuant to the company's share option plan, and the options remain subject to acceptance by the respective grantees before they become effective.